title: Effect of US Drug Enforcement Administration's Rescheduling of Hydrocodone Combination Analgesic Products on Opioid Analgesic Prescribing.
authors.affiliation: Office of the Assistant Secretary for Planning and Evaluation, US Department of Health and Human Services, Washington, DC.
authors.forename: Christopher M
authors.initials: CM
authors.lastname: Jones
authors.affiliation: Office of the Commissioner, US Food and Drug Administration, Silver Spring, Maryland.
authors.forename: Peter G
authors.initials: PG
authors.lastname: Lurie
authors.affiliation: Office of the Commissioner, US Food and Drug Administration, Silver Spring, Maryland.
authors.forename: Douglas C
authors.initials: DC
authors.lastname: Throckmorton
mesh_terms: D000701:Analgesics, Opioid / Q000627:therapeutic use; D004338:Drug Combinations; D011307:Drug Prescriptions / Q000592:standards*; D006801:Humans; D006853:Hydrocodone / Q000627:therapeutic use; D007880:Legislation, Drug; D016014:Linear Models; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data / Q000639:trends*; D055553:Prescription Drugs / Q000627:therapeutic use; D011320:Primary Health Care / Q000706:statistics & numerical data / Q000639:trends; D014481:United States
chemical_list: D000701:Analgesics, Opioid; D004338:Drug Combinations; D055553:Prescription Drugs; D006853:Hydrocodone